# MEDA Ventures

MEDA Ventures is a Venture Capital based in Arlington, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Arlington, United States
- **Region:** North America
- **Address:** Arlington, VA, United States
- **Founded:** 1953
- **Assets under management:** Undisclosed
- **Website:** www.meda.vc
- **LinkedIn:** https://www.linkedin.com/company/medaventures

## Regulatory record

- **Reports private funds:** No

## About

MEDA Ventures is a physician and scientist-founded healthcare venture capital group. Its partners include physicians, payors, scientists and industry experts who have been customers, decision-makers, exited entrepreneurs, innovators, and key opinion leaders in healthcare. The firm supports portfolio companies beyond a check through networks, diligence spanning science, finance, reimbursement and adoption, and access to medical centers.

## Sectors

- Digital Health
- Healthcare Services
- Therapeutics
- Medical Devices

## People

- Elizabeth Cho-Fertikh — Managing Partner
- Tomas Philipson — Managing Partner
- Carolyn Campbell — Managing Partner

## Questions

### Who makes investment decisions at MEDA Ventures?

Investment decisions are led by Managing Partners Elizabeth Cho-Fertikh (therapeutics, regulatory strategy), Tomas Philipson (health economics), and Carolyn Campbell (fund management, legal). The firm’s venture partners — practicing physicians and researchers from institutions like Mass General Brigham and Stanford — contribute to deal-specific diligence, but the Managing Partners retain decision-making authority.

### What does MEDA Ventures’ clinical-trial underwriting product do?

According to MEDA’s website, the firm has developed a product that can underwrite coverage of a portfolio company’s clinical-trial costs, financially protecting both startups and investors from trial failures. The mechanics — whether a balance-sheet commitment, an insurance wrapper, or a third-party facility — have not been publicly detailed. It is positioned as a differentiated de-risking tool for early-stage healthcare companies.

### How does MEDA Ventures source its deals?

The firm attributes deal flow to its partners’ standing as former healthcare customers, clinicians, and key opinion leaders. Its network of early-adopting medical centers is cited as the channel that attracts startups and co-investors. The firm states this network also supports business development and potential exits for portfolio companies.

### What stages does MEDA Ventures target with its investments?

MEDA Ventures focuses on early-stage healthcare companies, specifically seed and start-up phases, as described in its own materials. Its portfolio companies include Nested Knowledge and DynamiCare Health, both of which were at early commercial or clinical-validation stages when the relationship was disclosed.

## Related profiles

- [Medical Angels](https://altss.com/profile/medangels)
- [MedCap](https://altss.com/profile/medcap)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/meda-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology